Emergent BioSolutions presented the quarterly figures for the most recent quarter – closing date December 31, 2020 – at the financial conference on February 19, 2021.
In terms of EPS, USD 3.67 per share was reported. Emergent BioSolutions made $ 1.57 per share last year.
Compared to the same period in the previous year, Emergent BioSolutions posted a sales increase of 61.76 percent in the quarter just ended. The company put sales at $ 583.0 million compared to $ 360.4 million in the prior-year quarter.
The EPS for the full year was put at USD 7.88. In the previous year, Emergent BioSolutions earned $ 2.91 per share.
Compared to the previous year, Emergent BioSolutions achieved a sales increase of 40.63 percent in the past fiscal year. Sales were $ 1.56 billion. In the previous year, the books were $ 1.11 billion.
For the past year as a whole, analysts had forecast earnings per share of USD 7.35 and sales of USD 1.55 billion.